| Style | Citing Format |
|---|---|
| MLA | Berenjian K, et al.. "Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation." Iranian Journal of Pharmaceutical Research, vol. 26, no. 1, 2027, pp. -. |
| APA | Berenjian K, Gholipour Z, Khoshayand M, Sharifzadeh M, Rouini M, Ardakani YH (2027). Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation. Iranian Journal of Pharmaceutical Research, 26(1), -. |
| Chicago | Berenjian K, Gholipour Z, Khoshayand M, Sharifzadeh M, Rouini M, Ardakani YH. "Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation." Iranian Journal of Pharmaceutical Research 26, no. 1 (2027): -. |
| Harvard | Berenjian K et al. (2027) 'Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation', Iranian Journal of Pharmaceutical Research, 26(1), pp. -. |
| Vancouver | Berenjian K, Gholipour Z, Khoshayand M, Sharifzadeh M, Rouini M, Ardakani YH. Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation. Iranian Journal of Pharmaceutical Research. 2027;26(1):-. |
| BibTex | @article{ author = {Berenjian K and Gholipour Z and Khoshayand M and Sharifzadeh M and Rouini M and Ardakani YH}, title = {Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {26}, number = {1}, pages = {-}, year = {2027} } |
| RIS | TY - JOUR AU - Berenjian K AU - Gholipour Z AU - Khoshayand M AU - Sharifzadeh M AU - Rouini M AU - Ardakani YH TI - Impact of Mild Traumatic Brain Injury (Mtbi) on Cyp2d6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation JO - Iranian Journal of Pharmaceutical Research VL - 26 IS - 1 SP - EP - PY - 2027 ER - |